Clinical study on hepatocellular carcinoma with extrahepatic malignancies

Area of Science:

• Hepatology
• Oncology
• Gastroenterology

Background:

• Hepatocellular carcinoma (HCC) is a primary liver cancer.
• Extrahepatic malignancies (EHM) can coexist with HCC.
• Understanding the relationship between HCC and EHM is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate the incidence and characteristics of extrahepatic malignancies (EHM) in patients with hepatocellular carcinoma (HCC).
• To compare the clinical features and etiological factors between HCC patients with and without EHM.
• To explore potential differences in the etiology of HCC with EHM.

Main Methods:

• Retrospective analysis of 146 consecutive HCC patients.
• Identification and classification of coexisting extrahepatic malignancies.
• Comparison of clinical data, including hepatitis B surface antigen status, liver cirrhosis, and indocyanine green retention rate, between HCC with EHM and HCC alone groups.

Main Results:

• 10 out of 146 HCC patients (6.8%) presented with one or two EHM.
• Gastric and colon cancers were the most common associated malignancies.
• Patients with HCC and EHM showed significantly lower incidence of liver cirrhosis and indocyanine green retention compared to HCC alone.
• All patients with HCC and EHM were hepatitis B surface antigen negative.

Conclusions:

• The presence of extrahepatic malignancies in HCC patients is relatively uncommon but significant.
• Hepatocellular carcinoma with coexisting extrahepatic malignancies may have a different etiological background compared to HCC alone, particularly in the Japanese population.
• Further research is warranted to elucidate the distinct pathways involved in the development of HCC with EHM.